$CDLX

Cardlytics: Q2 Earnings Snapshot

Cardlytics (CDLX) reported a Q2 loss of $14.9 million, or $2.58 per share. Adjusted for discontinued operations, the loss was $1.50 per share. Revenue was $36.9 million. For the quarter ending September, the company expects revenue of $34 million to $39 million.

Original reporting
Published Aug 5, 2026, 10:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 11:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CDLX
Bearish
medium confidence
Mentioned
$CDLX
Relevance
8/10
AlphAI data visualization · based on local3news.com
Decision brief

The 30-second read

$CDLXBearishMed
01

Why it matters

Traders can update models and expectations using the disclosed Q2 results and the stated Q3 revenue range for near-term sentiment and positioning.

02

Market read

Company-specific earnings and guidance provide a fresh basis for adjusting near-term expectations for CDLX.

03

What to watch

The article does not include margin, cash flow, or segment detail, so traders may be over-weighting the headline loss without assessing underlying operating trends.

Relevance 8/10Novelty 7/10Timing: reported Q2 results and Q3 revenue guidance on Wednesday

Background

AP earnings snapshot for Cardlytics, including quarterly loss, revenue, and next-quarter revenue guidance.

Company-level read

Ticker impact

$CDLXBearishMedium confidence
Context

Cardlytics reported Q2 loss of $2.58 per share and revenue of $36.9 million, plus Q3 revenue guidance of $34M to $39M.

Expected impact

Likely downside bias on any pre-market reaction if investors focus on losses and the breadth of the revenue outlook.

Evidence & confidence

The article discloses a quarterly loss and provides explicit next-quarter revenue guidance, which typically moves small-cap ad-tech/marketing analytics names on expectations.

Market effects

Adds datapoint on demand and monetization trajectory for customer engagement/marketing analytics providers.

Limited, as the disclosure is company-specific.

Low, no cross-border or macro linkage described.

Counterpoint

Investors may focus less on GAAP loss and more on revenue trajectory versus prior expectations, using the guidance range as a signal of stabilization.

Key entities

  • Cardlytics, Inc.

    Reported Q2 loss and revenue, and provided Q3 revenue guidance range.

Related articles

$CDLXMedAI 8/10

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

Cardlytics (CDLX) reported Q2 2026 results on an earnings call. Revenue was $36.9M, down 36% YoY, with billings $65.5M (-34%) and adjusted contribution $21.3M (-32%). Net loss was $14.9M. Q3 2026 guidance: billings $61M-$67M, revenue $34M-$39M, adjusted EBITDA $0M-$3M. Cash was $28M.

$CDLXMed

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics, Inc. (CDLX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance • Company delivers strong second quarter results: ◦ Revenues of $36.9 million ◦ Billings of $65.5 million ◦ Adjusted Contribution of $21.3 million ◦ Net Loss of $(14.9) million

$NKEHighAI 8/10

Analyst warns Nike's best quarter this year may be behind it

Nike (NKE) reported Q1 earnings beating estimates, but investors sold shares. Morgan Stanley warns this may be the best quarter of the year, citing inventory risks and weaker forecasts. Nike expects fiscal 2027 revenue to decline by a high single-digit percentage. Analysts cut price targets, with Morgan Stanley suggesting a 50% drop in EPS over the next three quarters.

$CCLHighAI 8/10

Carnival (CCL) Reports Strong Q3 Earnings, Dividend Sustainabili

Carnival Corporation (CCL) reported Q3 earnings of $1.43 per share, beating estimates by $0.08. The company offers a 1.56% dividend yield with a 19% payout ratio, and its stock is fairly valued at $25.76. CCL has a GF Score of 76, reflecting strengths in profitability and valuation but weaknesses in financial strength. Institutional investors show mixed sentiment, with 9 gurus increasing positions and 4 trimming them, while insiders sold $13.5 million in shares over the past year.

$MUMedAI 8/10

Micron Just Extended Its Forecast for the AI Build-Out to 2031. Its Stock Is Bound to Defy History.

Micron Technology updated its forecast, stating that customer demand for memory chips will extend to 2031, up from 2030. The company reported Q4 fiscal 2027 revenue of $54.2 billion, up from $41.5 billion last quarter and $11.3 billion year-over-year. Micron projects $61.5 billion in revenue for the next quarter, citing strong AI-driven demand and supply constraints.